Baseline metabolic signatures predict clinical outcomes in immunotherapy-treated melanoma patients: a pilot study.
- DOI
- 10.3389/fimmu.2025.1536710
- Published
- 2025
- Container
- Frontiers in immunology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fimmu.2025.1536710,
title = {Baseline metabolic signatures predict clinical outcomes in immunotherapy-treated melanoma patients: a pilot study.},
author = {De Summa S and De Palma G and Ghini V and Apollonio B and De Risi I and Tufaro A and Strippoli S and Luchinat C and Tenori L and Guida M},
year = {2025},
journal = {Frontiers in immunology},
doi = {10.3389/fimmu.2025.1536710},
url = {https://doi.org/10.3389/fimmu.2025.1536710}
}RIS
TY - JOUR TI - Baseline metabolic signatures predict clinical outcomes in immunotherapy-treated melanoma patients: a pilot study. AU - De Summa S AU - De Palma G AU - Ghini V AU - Apollonio B AU - De Risi I AU - Tufaro A AU - Strippoli S AU - Luchinat C AU - Tenori L AU - Guida M PY - 2025 JO - Frontiers in immunology DO - 10.3389/fimmu.2025.1536710 UR - https://doi.org/10.3389/fimmu.2025.1536710 ER -
APA
S, D. S., G, D. P., V, G., B, A., I, D. R., A, T., S, S., C, L., L, T., & M, G. (2025). Baseline metabolic signatures predict clinical outcomes in immunotherapy-treated melanoma patients: a pilot study.. Frontiers in immunology. https://doi.org/10.3389/fimmu.2025.1536710
Source records
- pubmed · retrieved 2026-09-26T11:01:12.466Z